skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists

Authors:
; ; ; ; ; ; ;  [1]
  1. (UCIN)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
NIHAHA
OSTI Identifier:
1171862
Resource Type:
Journal Article
Resource Relation:
Journal Name: J. Biol. Chem.; Journal Volume: 290; Journal Issue: (8) ; 02, 2015
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Nolan, Kristof, Kattamuri, Chandramohan, Luedeke, David M., Angerman, Elizabeth B., Rankin, Scott A., Stevens, Mariana L., Zorn, Aaron M., and Thompson, Thomas B.. Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists. United States: N. p., 2016. Web. doi:10.1074/jbc.M114.628412.
Nolan, Kristof, Kattamuri, Chandramohan, Luedeke, David M., Angerman, Elizabeth B., Rankin, Scott A., Stevens, Mariana L., Zorn, Aaron M., & Thompson, Thomas B.. Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists. United States. doi:10.1074/jbc.M114.628412.
Nolan, Kristof, Kattamuri, Chandramohan, Luedeke, David M., Angerman, Elizabeth B., Rankin, Scott A., Stevens, Mariana L., Zorn, Aaron M., and Thompson, Thomas B.. Wed . "Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists". United States. doi:10.1074/jbc.M114.628412.
@article{osti_1171862,
title = {Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1): Insights for the Functional Variability across Bone Morphogenetic Protein (BMP) Antagonists},
author = {Nolan, Kristof and Kattamuri, Chandramohan and Luedeke, David M. and Angerman, Elizabeth B. and Rankin, Scott A. and Stevens, Mariana L. and Zorn, Aaron M. and Thompson, Thomas B.},
abstractNote = {},
doi = {10.1074/jbc.M114.628412},
journal = {J. Biol. Chem.},
number = (8) ; 02, 2015,
volume = 290,
place = {United States},
year = {Wed Aug 24 00:00:00 EDT 2016},
month = {Wed Aug 24 00:00:00 EDT 2016}
}
  • A calmodulin (CaM)-like protein (hCLP) is expressed in human mammary epithelial cells but appears to be limited to certain epithelial cells such as those found in skin, prostate, breast and cervical tissues. A decrease in the expression of this protein is associated with the occurrence of tumors in breast epithelium. The structure of hCLP determined to 1.5 Å resolution by X-ray crystallography shows a distinct 30° displacement along the interconnecting central helix, when compared to the highly conserved structure of vertebrate CaM, resulting in a difference in the relative orientation of its two globular domains. Additionally, the electric surface potentialmore » landscape at the target protein binding regions on the two globular domains of hCLP is significantly different from those of CaM, indicating that the respective ranges of hCLP and hCaM target proteins do not fully overlap. Observations that hCLP can competitively inhibit CaM activation of target proteins also imply a role for hCLP in which it may also serve as a modulator of CaM activity in the epithelial cells where hCLP is expressed.« less
  • Bone morphogenetic protein 1 (BMP1) is a putative protease purified from extracts capable of inducing ectopic bone formation. A single mammalian gene apparently encodes alternatively spliced transcripts for BMP1, for a longer protein with a domain structure identical to that of the Drosophila dorsal-ventral patterning gene product tolloid (Tld), and for a third species of low abundance. Here we describe the organization of the 46-kb, 22-exon human BMP1/mTld gene that encodes these forms. Exons corresponding to each of the alternatively spliced transcripts are identified, and comparison with the Drosophila Tld gene reveals alignment of introns at only three positions. Themore » major BMP1/mTld transcription start site is found only 706 bp downstream of the polyadenylation site of the SFTP2 surfactant gene, and a previously reported highly polymorphic CA repeat is found within the BMP1/mTld first intron. These two findings place the BMP1/mTld gene between markers D8S298 and D8S5 on the genetic map. 42 refs., 5 figs.« less
  • Bone morphogenetic protein-1 (BMP-1), a metalloprotease isolated from osteogenic extracts of demineralized bone, is capable of cleaving the C-propeptides of procollagen types I, II, and III. A single mammalian gene produces alternatively spliced RNA transcripts for BMP-1 and for a second longer protein, designated mammalian tolloid (mTld) due to a domain structure identical to that of the Drosophilia dorsal-ventral patterning gene product tolloid (Tld). Here we report the use of a cDNA library, prepared from BMP-1/mTld-null mouse embryos, to solate cDNA clones for a novel mammalian protein with a domain structure identical to that of mTld. The new protein, designatedmore » mammalian tolloid-like (mTll), has 76% identity with mTld for amino acid residues in all domains downstream of, and including, the protease domain. In contrast, the N-terminal activation domains of the two proteins show little similarity. In situ hybridizations show the distribution of mTll RNA to overlap extensively that previously shown for the BMP-1 and mTld RNA forms. However, mTll shows additional strong expression in structures of the developing, neonatal, and adult brain in which expression of BMP-1 and mTld has not been observed. The murine mTl1 gene (Tll) is mapped to central chromosome 8, which is a different chromosomal location than that of the BMP-1/mTld gene. Loci for some developmental abnormalities map to the same general chromosomal location as Tll. 38 refs., 6 figs.« less